OCCUPATIONAL SAFETY AND HEALTH RESEARCH

Release Date:  August 18, 1999

PA NUMBER:  PA-99-143 (see replacement PA-04-038)

National Institute for Occupational Safety and Health
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Deafness and Other Communication Disorders
National Institute of Environmental Health Sciences

THIS PROGRAM ANNOUNCEMENT (PA) USES THE "MODULAR GRANT" AND "JUST-IN-TIME"
CONCEPTS.  IT INCLUDES DETAILED MODIFICATIONS TO STANDARD APPLICATION
INSTRUCTIONS THAT MUST BE USED WHEN PREPARING APPLICATIONS IN RESPONSE TO THIS
PA.

PURPOSE

The Centers for Disease Control and Prevention (CDC) and  the National
Institutes of Health (NIH) invite grant applications for research related to
the priority areas identified in the National Occupational Research Agenda
(NORA) that are described in the RESEARCH OBJECTIVES section.

The overall purpose of this grants program is to develop knowledge that can be
used in preventing occupational diseases and injuries and to better understand
their underlying pathophysiology.  This purpose is shared by several
components of the Public Health Service within the CDC and the NIH.  Within
CDC, the National Institute for Occupational Safety and Health (NIOSH) is the
only Federal Institute responsible for conducting research and making
recommendations for the prevention of work-related illnesses and injuries;
however, there are other Federal components that contribute significantly to
the research base for understanding the causes of occupational illnesses and
injuries.  Broad statements of interest for the sponsors of this program
announcement are given below, and more information about their individual
interests may be found on their respective internet sites.

NIOSH supports research to identify and investigate the relationships between
hazardous working conditions and associated occupational diseases and
injuries; to develop more sensitive means of evaluating hazards at work sites,
as well as methods for measuring early markers of adverse health effects and
injuries; to develop new protective equipment, engineering control technology,
and work practices to reduce the risks of occupational hazards; and to
evaluate the technical feasibility or application of a new or improved
occupational safety and health procedure, method, technique, or system.

The National Cancer Institute (NCI) supports training and research in the
basic, population-based, and clinical sciences related to the causes,
detection, prevention, diagnosis, prognosis, and treatment of cancer.  Basic
and applied research is also supported for advancing cancer control strategies
by investigating factors (e.g., exogenous exposures, genetic susceptibility,
behavioral and lifestyle patterns) influencing cancer risk in individuals and
population subgroups and by application of surveillance activities and
dissemination of public health information.

The National Heart, Lung and Blood Institute (NHLBI) supports an integrated
and coordinated program of basic research, clinical investigations and trials,
observational studies, and demonstration and education projects.  Research is
related to the causes, prevention, diagnosis, and treatment of heart, blood
vessel, lung, and blood diseases; and sleep disorders.  The NHLBI plans and
directs research in the development and evaluation of interventions and
devices related to prevention, treatment, and rehabilitation of patients
suffering from such diseases and disorders.  It also supports research on
clinical use of blood and all aspects of the management of blood resources.

The National Institute on Aging (NIA) supports research on basic mechanisms
involved in aging processes and the onset of age-related disease; social and
behavioral research on aging processes and the place of older people in
society; the structure and function of the aging nervous system and the
behavioral manifestations of the aging brain; and topics related to the
causes, prevention, and treatment of older people's health problems.

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) supports basic
and applied research on the causes, consequences, treatment and prevention of
alcohol-related problems including research into the effects of alcohol on the
human mind and body, prevention and treatment of alcohol abuse and alcoholism
among general and specific populations, the epidemiology of alcoholism and
alcohol-related problems, and health services research.

The National Institute of Allergy and Infectious Diseases (NIAID) conducts,
fosters, and supports research and research training programs directed at
finding the cause of and improved methods for diagnosing, treating, and
preventing immunologic and infectious diseases which significantly affect
public health.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases
(NIAMS) supports basic, clinical, and epidemiologic research and research
training and disseminates information on many forms of arthritis and diseases
of the musculoskeletal system and the skin, including (1) the normal structure
and function of joints, muscles, bones, and skin and (2) clinical research in
the fields of rheumatology, orthopedics, dermatology, metabolic bone diseases,
heritable disorders of bone and cartilage, inherited and inflammatory muscle
diseases, and sports- and rehabilitation medicine.

The National Institute on Deafness and Other Communication Disorders (NIDCD)
supports biomedical and behavioral research and research training in the
normal and disordered processes of hearing, balance, smell, taste, voice,
speech and language; disease prevention and health promotion; special
biomedical and behavioral problems associated with people who have
communication impairments or disorders; and creation of devices which
substitute for lost and impaired sensory and communication function.

The National Institute of Environmental Health Sciences (NIEHS) supports
research to reduce the burden of human illness and dysfunction from exposure
to physical and chemical agents in the environment by understanding the
interactions between environmental exposures, individual susceptibility and
time.

HEALTHY PEOPLE 2000

CDC and NIH are committed to achieving the health promotion and disease
prevention objectives of "Healthy People 2000," a national activity to reduce
morbidity and mortality and improve the quality of life.  This program
announcement is related to the priority areas of occupational safety and
health and unintentional injuries.  Potential applicants may obtain a copy of 
"Healthy People 2000" (Full Report, Stock No. 017-001-00474-0 or Summary
Report, Stock No. 017-001-00473-1) through the Superintendent of Documents,
Government Printing Office, Washington, DC 20402-9325, telephone (202)
512-1800, or at http://www.crisny.org/health/us/health7.html

ELIGIBILITY REQUIREMENTS

Applications may be submitted by domestic and foreign, public and private
nonprofit and for-profit organizations and by governments and their agencies;
that is, universities, colleges, research institutions, hospitals, other
public and private nonprofit and for-profit organizations, State and local
governments or their bona fide agents, and federally recognized Indian tribal
governments, Indian tribes, or Indian tribal organizations.  Racial/ethnic
minority individuals, women, and persons with disabilities are encouraged to
apply as Principal Investigators.

Note:  Public Law 104-65 states that an organization described in section
501(c)(4) of the Internal Revenue Code of 1986 which engages in lobbying
activities is not eligible to receive Federal funds constituting an award,
grant (cooperative agreement), contract, loan, or any other form.

MECHANISM OF SUPPORT

This PA will use the research project grants (R01) mechanism.  A research
project grant application should be designed to establish, discover, develop,
elucidate, or confirm information relating to occupational safety and health,
including innovative methods, techniques, and approaches for dealing with
problems.  These studies may generate information that is readily available to
solve problems or contribute to a better understanding of the causes of
work-related diseases and injuries.

Grants are funded for 12-month budget periods in project periods up to five
years.  Continuation awards within the project period are made on the basis of
satisfactory progress and on the availability of funds.

Specific application instructions have been modified to reflect "MODULAR
GRANT" and "JUST-IN-TIME" streamlining efforts being examined by the NIH. 
Complete and detailed instructions and information on Modular Grant
applications can be found at
https://grants.nih.gov/grants/funding/modular/modular.htm

RESEARCH OBJECTIVES

In today's society, Americans are working more hours than ever before.  The
workplace environment profoundly affects health; each of us, simply by going
to work each day, may face hazards that threaten our health and safety. 
Risking one's life or health should never be considered merely part of the
job.  In 1970, Congress passed the Occupational Safety and Health Act to
ensure Americans the right to "safe and healthful working conditions," yet
workplace hazards continue to inflict a tremendous toll in both human and
economic costs.  Employers reported 5.8 million work injuries in 1996 and
439,000 cases of occupational illness.  An average of 16 American workers die
each day from injuries on the job.  Moreover, even the most conservative
estimates find that about 137 additional workers die each day from workplace
diseases.  Additionally, in 1996 occupational injuries and deaths cost $121
billion in wages and lost productivity, administrative expenses, health care
and other costs.  This does not include the cost of occupational disease. 
These occupational injuries and diseases create needless human suffering, a
tremendous burden upon health care resources, and an enormous drain on U.S.
productivity.

In 1996, the National Institute for Occupational Safety & Health (NIOSH) and
its partners in the public and private sectors developed the National
Occupational Research Agenda (NORA) to provide a framework to guide
occupational safety and health research into the next decade, not only for
NIOSH, but also for the entire occupational safety and health community.
Approximately 500 organizations and individuals outside NIOSH provided input
into the development of the National Occupational Research Agenda (NORA). 
This attempt to guide and coordinate research nationally is responsive to a
broadly perceived need to address systematically those topics that are most
pressing and most likely to yield gains to the worker and the nation.  Fiscal
constraints on occupational safety and health research are increasing, making
even more compelling the need for a coordinated and focused research agenda.

Potential applicants may obtain a copy of the "National Occupational Research
Agenda" (HHS, CDC, NIOSH Publication No.96-115) from the National Institute
for Occupational Safety and Health, telephone (800) 356-4674.  It is also
available on the internet at "http://www.cdc.gov/niosh/nora.html".

The agenda identifies 21 research priorities and reflects an attempt to
consider both current and emerging needs.  The priority areas are not ranked;
each is considered to be of equal importance.  The NORA priority research
areas are grouped into three categories: Disease and Injury, Work Environment
and Workforce, and Research Tools and Approaches.

Applications responding to this announcement will be reviewed for their
responsiveness to the following program interests and their potential for
developing knowledge that can be used in preventing occupational diseases and
injuries.  Applicants should provide a statement about which NORA area is
being addressed and a rationale for how the proposal will contribute to the
specified priority area (this information should be placed in the "Background
and Significance" section of the "Research Plan" of the application). 
Assignment of applications to sponsoring Institutes will be made on the basis
of matching the research topics with the appropriate programmatic interests. 
Applicants are encouraged to contact individuals listed under INQUIRIES if
they wish to discuss the relevance of their research ideas.

NORA Priority Research Areas are:

Disease and Injury

1.  Allergic and Irritant Dermatitis
2.  Asthma and Chronic Obstructive Pulmonary Disease
3.  Fertility and Pregnancy Abnormalities
4.  Hearing Loss
5.  Infectious Diseases
6.  Low Back Disorders
7.  Musculoskeletal Disorders of the Upper Extremities
8.  Traumatic Injuries

Work Environment and Workforce

9.  Emerging Technologies
10. Indoor Environment
11. Mixed Exposures
12. Organization of Work
13. Special Populations at Risk

Research Tools and Approaches

14. Cancer Research Methods
15. Control Technology and Personal Protective Equipment
16. Exposure Assessment Methods
17. Health Services Research
18. Intervention Effectiveness Research
19. Risk Assessment Methods
20. Social and Economic Consequences of Workplace Illness and Injury
21. Surveillance Research Methods

Potential applicants with questions concerning the acceptability of their
proposed work are strongly encouraged to seek programmatic technical
assistance from the contact listed in this announcement under the section
"INQUIRIES."

SPECIAL REQUIREMENTS

Human Subjects

If a project involves research on human subjects, assurance (in accordance
with Department of Health and Human Services Regulations, 45 CFR Part 46) of
the protection of human subjects is required.  In addition to other applicable
committees, Indian Health Service (IHS) institutional review committees also
must review the project if any component of IHS will be involved with or will
support the research.  If any American Indian community is involved, its
tribal government must also approve that portion of the project applicable to
it.  Unless the grantee holds a Multiple Project Assurance, a Single Project
Assurance is required, as well as an assurance for each subcontractor or
cooperating institution that has immediate responsibility for human subjects. 
The Office for Protection from Research Risks (OPRR) at the National
Institutes of Health (NIH) negotiates assurances for all activities involving
human subjects that are supported by the Department of Health and Human
Services.

It is the policy of the CDC and the NIH that women and members of minority
groups and their sub-populations must be included in all supported biomedical
and behavioral research projects involving human subjects, unless a clear and
compelling rationale and justification is provided that inclusion is
inappropriate with respect to the health of the subjects or the purpose of the
research.

All investigators proposing research involving human subjects should read the
"NIH Guidelines For Inclusion of Women and Minorities as Subjects in Clinical
Research," which have been published in the Federal Register of March 28, 1994
(FR 59 14508-14513) and in the NIH Guide for Grants and Contracts, Volume 23,
Number 11, March 18, 1994.  It is also available at:
http://www.nih.gov/grants/guide/1994/94.03.18/notice-nih-guideline008.html

Animal Subjects Requirements

If the proposed project involves research on animal subjects, compliance with
the "PHS Policy on Humane Care and Use of Laboratory Animals by Awardee
Institutions" is required.  An applicant (as well as each subcontractor or
cooperating institution that has immediate responsibility for animal subjects)
proposing to use vertebrate animals in CDC and NIH supported activities must
file (or have on file) the Animal Welfare Assurance with the Office for the
Protection from Research Risks (OPRR) at the National Institutes of Health.
The applicant must provide in the application the assurance of compliance
number and evidence of review and approval (including the date of the most
recent approval) by the Institutional Care and Use Committee (IACUC).

INCLUSION OF WOMEN AND MINORITIES IN RESEARCH INVOLVING HUMAN SUBJECTS

It is the policy of the CDC and NIH to ensure that individuals of both sexes
and the various racial and ethnic groups will be included in supported
research projects involving human subjects, whenever feasible and appropriate.
Racial and ethnic groups are those defined in OMB Directive No. 15 and include
American Indian or Alaska Native, Asian, Black or African American, Hispanic
or Latino, Native Hawaiian or Other Pacific Islander.  Applicants shall ensure
that women, racial and ethnic minority populations are appropriately
represented in applications for research involving human subjects.  Where
clear and compelling rationale exist that inclusion is inappropriate or not
feasible, this situation must be explained as part of the application.  This
policy does not apply to research studies when the investigator cannot control
the race, ethnicity, and/or sex of subjects.  Further guidance to this policy
is contained in the Federal Register, Vol. 60, No. 179, pages 47947-47951, and
dated Friday, September 15, 1995.

INCLUSION OF CHILDREN AS PARTICIPANTS IN RESEARCH INVOLVING HUMAN SUBJECTS

It is the policy of NIH that children (i.e., individuals under the age of 21)
must be included in all human subjects research, conducted or supported by the
NIH, unless there are scientific and ethical reasons not to include them. This
policy applies to all initial (Type 1) applications submitted for receipt
dates after October 1, 1998.

All investigators proposing research involving human subjects should read the
"NIH Policy and Guidelines on the Inclusion of Children as Participants in
Research Involving Human Subjects" that was published in the NIH Guide for
Grants and Contracts, March 6, 1998, and is available at the following URL
address: http://www.nih.gov/grants/guide/notice-files/not98-024.html.

LOBBYING RESTRICTIONS

Applicants should be aware of restrictions on the use of HHS funds for
lobbying of Federal or State legislative bodies. Under the provisions of 31
U.S.C. Section 1352, recipients (and their subtier contractors) are prohibited
from using appropriated Federal funds (other than profits from a Federal
contract) for lobbying congress or any Federal agency in connection with the
award of a particular contract, grant, cooperative agreement, or loan. This
includes grants/cooperative agreements that, in whole or in part, involve
conferences for which Federal funds cannot be used directly or indirectly to
encourage participants to lobby or to instruct participants on how to lobby.

In addition no part of PHS appropriated funds, shall be used, other than for
normal and recognized executive-legislative relationships, for publicity or
propaganda purposes, for the preparation, distribution, or use of any kit,
pamphlet, booklet, publication, radio, television, or video presentation
designed to support or defeat legislation pending before the Congress or any
State or local legislature, except in presentation to the Congress or any
State or local legislature itself. No part of the appropriated funds shall be
used to pay the salary or expenses of any grant or contract recipient, or
agent acting for such recipient, related to any activity designed to influence
legislation or appropriations pending before the Congress or any State or
local legislature.

APPLICATION PROCEDURES

Applications are to be submitted on the grant application form PHS 398 (rev.
4/98) and will be accepted at the standard application receipt dates indicated
in the application kit.  These forms are available at most institutional
offices of sponsored research and from the Division of Extramural Outreach and
Information Resources, National Institutes of Health, 6701 Rockledge Drive,
MSC 7910, Bethesda, MD 20892-7910, telephone 301/710-0267, email:
grantsinfo@nih.gov.  Application kits are also available at:
http://www.nih.gov/grants/forms.htm

Applicants planning to submit an investigator-initiated new (type 1),
competing continuation (type 2), competing supplement, or any amended/revised
version of the preceding grant application types requesting $500,000 or more
in direct costs for any year are advised to contact the Institute or Center
(IC) program staff before submitting the application, i.e., as plans for the
study are being developed.  The applicant must obtain agreement from the IC
staff that the IC will accept the application for consideration for award. 
Finally, the applicant must identify, in a cover letter sent with the
application, the staff member and Institute or Center who agreed to accept
assignment of the application.  Refer to the NIH Guide for Grants and
Contracts, March 20, 1998 at 
https://grants.nih.gov/grants/guide/notice-files/not98-030.html.

The modular grant concept establishes specific modules in which direct costs
may be requested as well as a maximum level for requested budgets. Only
limited budgetary information is required under this approach.  The
just-in-time concept allows applicants to submit certain information only when
there is a possibility for an award. It is anticipated that these changes will
reduce the administrative burden for the applicants, reviewers and Institute
staff.  The research grant application form PHS 398 (rev. 4/98) is to be used
in applying for  these grants, with the modifications noted below.

BUDGET INSTRUCTIONS

Modular Grant applications will request direct costs in $25,000 modules, up to
a total direct cost request of $250,000 per year. (Applications that request
more than $250,000 direct costs in any year must follow the traditional PHS
398 application instructions.)  The total direct costs must be requested in
accordance with the program guidelines and the modifications made to the
standard PHS 398 application instructions described below:

PHS 398

o  FACE PAGE: Items 7a and 7b should be completed, indicating Direct Costs (in
$25,000 increments up to a maximum of $250,000) and Total Costs [Modular Total
Direct plus Facilities and Administrative  (F&A) costs] for the initial budget
period Items 8a and 8b should be completed indicating the Direct and Total
Costs for the entire proposed period of support.

o DETAILED BUDGET FOR THE INITIAL BUDGET PERIOD - Do not complete Form Page 4
of the PHS 398. It is not required and will not be accepted with the
application.

o BUDGET FOR THE ENTIRE PROPOSED PERIOD OF SUPPORT - Do not complete the
categorical budget table on Form Page 5 of the PHS 398. It is not required and
will not be accepted with the application.

o NARRATIVE BUDGET JUSTIFICATION - Prepare a Modular Grant Budget Narrative
page. (See https://grants.nih.gov/grants/funding/modular/modular.htm for sample
pages.) At the top of the page, enter the total direct costs requested for
each year.  This is not a Form page.

o Under Personnel, List key project personnel, including their names, percent
of effort, and roles on the project. No individual salary information should
be provided. However, the applicant should use the NIH appropriation language 
salary cap and the NIH policy for graduate student compensation in developing
the budget request.

For Consortium/Contractual costs, provide an estimate of total costs (direct
plus facilities and administrative) for each year, each rounded to the nearest
$1,000. List the individuals/organizations with whom consortium or contractual
arrangements have been made, the percent effort of key personnel, and the role
on the project. Indicate whether the collaborating institution is foreign or
domestic. The total cost for a consortium/contractual arrangement is included
in the overall requested modular direct cost amount.  Include the Letter of
Intent to establish a consortium.

Provide an additional narrative budget justification for any variation in the
number of modules requested.

o BIOGRAPHICAL SKETCH - The Biographical Sketch provides information used by 
reviewers in the assessment of each individual's qualifications for a specific
role in the proposed project, as well as to evaluate the overall
qualifications of the research team. A biographical sketch is required for all
key personnel, following the instructions below. No more than three pages may
be used for each person. A sample biographical sketch may be viewed at: 
https://grants.nih.gov/grants/funding/modular/modular.htm

- Complete the educational block at the top of the form page;
- List position(s) and any honors;
- Provide information, including overall goals and responsibilities, on
research projects ongoing or completed during the last three years.
- List selected peer-reviewed publications, with full citations;

o CHECKLIST - This page should be completed and submitted with the
application. If the F&A rate agreement has been established, indicate the type
of agreement and the date. All appropriate exclusions must be applied  in the
calculation of the F&A costs for the initial budget period and all future
budget years.

o The applicant should provide the name and phone number of the individual to
contact concerning fiscal and administrative issues if additional information
is necessary following the initial review.

Applicants not conforming to these guidelines will be considered unresponsive
and will be returned without further review.

The title and number of the program announcement must be typed on line 2 of
the face page of the application form, and the YES box must be marked.  Submit
a signed, typewritten original of the application, including the Checklist,
and five signed, photocopies, in one package to:

CENTER FOR SCIENTIFIC REVIEW
NATIONAL INSTITUTES OF HEALTH
6701 ROCKLEDGE DRIVE, ROOM 1040, MSC 7710
BETHESDA, MD 20892-7710
BETHESDA, MD 20817 (for express/courier service)

REVIEW CONSIDERATIONS

Applications will be assigned on the basis of established PHS referral
guidelines.  An appropriate scientific review group convened in accordance
with the standard NIH peer review procedures will evaluate applications for
scientific and technical merit.  As part of the initial merit review, all
applications will receive a written critique and undergo a process in which
only those applications deemed to have the highest scientific merit, generally
the top half of applications under review, will be discussed, assigned a
priority score, and receive a second level review by the appropriate national
advisory council or board.

Review Criteria

In the written comments reviewers will be asked to discuss the following
aspects of the application in order to judge the likelihood that the proposed
research will have a substantial impact on the pursuit of these goals. Each of
these criteria will be addressed and considered in assigning the overall
score, weighting them as appropriate for each application. Note that the
application does not need to be strong in all categories to be judged likely
to have major scientific impact and thus deserve a high priority score. For
example, an investigator may propose to carry out important work that by its
nature is not innovative but is essential to move a field forward.

1.  Significance: Does this study address an important problem? If the aims of
the application are achieved, how will scientific knowledge be advanced? What
will be the effect of these studies on the concepts or methods that drive this
field?

2.  Approach: Are the conceptual framework, design, methods, and analyses
adequately developed, well-integrated, and appropriate to the aims of the
project? Does the applicant acknowledge potential problem areas and consider
alternative tactics?

3.  Innovation: Does the project employ novel concepts, approaches or method?
Are the aims original and innovative? Does the project challenge existing
paradigms or develop new methodologies or technologies?

4.  Investigator: Is the investigator appropriately trained and well suited to
carry out this work? Is the work proposed appropriate to the experience level
of the principal investigator and other researchers (if any)?

5.  Environment: Does the scientific environment in which the work will be
done contribute to the probability of success? Do the proposed experiments
take advantage of unique features of the scientific environment or employ
useful collaborative arrangements? Is there evidence of institutional support?

In addition to the above criteria, all applications will be reviewed with
respect to the following:

o The adequacy of plans to include both genders, minorities and their
subgroups, and children as appropriate for the scientific goals of the
research. Plans for the recruitment and retention of subjects will also be
evaluated.

o The reasonableness of the proposed budget and duration in relation to the
proposed research.

o The adequacy of the proposed protection for humans, animals or the
environment, to the extent they may be adversely affected by the project
proposed in the application.

AWARD CRITERIA

Applications will compete for available funds with all other approved
applications.  The following will be considered in making funding decisions:
quality of the proposed project as determined by peer review, availability of
funds, and institutional program priority.

INQUIRIES

Inquiries are encouraged.  The opportunity to clarify any issues or questions
from potential applicants is welcome.

Direct inquiries regarding programmatic issues to:

Roy M. Fleming, Sc.D.
Research Grants Program
National Institute for Occupational Safety and Health
1600 Clifton Road, N.E.
Building 1, Room 3053, MS D-30
Atlanta, GA  30333
Telephone:  (404) 639-3343
FAX:  (404) 639-4616
Email:  rmf2@cdc.gov

Kumiko Iwamoto, M.D., Dr.P.H.
Epidemiology and Genetics Research Program
National Cancer Institute
6130 Executive Boulevard, Room 535
Bethesda, MD  20892-7395
Telephone:  (301) 435-4911
FAX:  (301) 402-4279
Email:  ki6n@nih.gov

Gail Weinmann, M.D.
Division of Lung Diseases
National Heart, Lung, and Blood Institute
6701 Rockledge Drive, Suite 10018, MSC 7952
Bethesda, MD  20892
Telephone:  (301) 435-0202
FAX:  (301) 480-3557
Email:  weinmang@gwgate.nhlbi.nih.gov

Sidney M. Stahl, Ph.D.
Behavioral and Social Research Program
National Institute on Aging
7201 Wisconsin Avenue, Room 533
Bethesda, MD  20892
Telephone:  (301) 402-4156
FAX:  (301) 402-0051
Email:  sidney_stahl@nih.gov

Susan Martin, Ph.D.
Division of Clinical and Prevention Research
National Institute on Alcohol Abuse and Alcoholism
6000 Executive Boulevard MSC 7003
Bethesda, MD  20892-7003
Telephone:  (301) 443-8767
FAX:  (301) 443-8774
Email:  smartin@willco.niaaa.nih.gov

Dr. Marshall Plaut
Division of Allergy, Immunology and Transplantation
National Institute of Allergy and Infectious Diseases
6700-B Rockledge Drive, Room 5146, MSC 7640
Bethesda, MD  20892-7640
Telephone:  (301) 496-9873
FAX:  (301) 402-0175
Email:  MPlaut@niaid.nih.gov

Dr. George W. Counts
Division of Microbiology and Infectious Diseases
National Institute of Allergy and Infectious Diseases
6700-B Rockledge Drive, Room 3144, MSC 7630
Bethesda, MD  20892-7630
Telephone: (301) 496-1884
FAX:  (301) 480-4528
Email:  gc23a@nih.gov

Alan Moshell, M.D.
Skin Diseases Branch
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Natcher Building, Room 5AS-25L
Bethesda, MD  20892-6500
Telephone:  (301) 594-5017
FAX:  (301) 480-4543
Email:  am40j@nih.gov

James S. Panagis, M.D., M.P.H.
Musculoskeletal Diseases Branch
National Institute of Arthritis and Musculoskeletal and Skin Diseases
45 Center Drive, Room 5AS-37K, MSC 4500
Bethesda, MD  20892-6500
Telephone:  (301) 594-5055
FAX:  (301) 480-4543
Email:  jp149d@nih.gov

Amy Donahue, Ph.D.
Hearing and Balance/Vestibular Sciences Branch
National Institute on Deafness and Other Communication Disorders
6120 Executive Boulevard, Suite 400C, MS-7180
Bethesda, MD  20892-7180
Telephone:  (301) 402-3458
FAX:  (301) 402-6251
Email:  amy_donahue@nih.gov

Gwen W. Collman, Ph.D.
Division of Extramural Research and Training
National Institute of Environmental Health Sciences
P.O. Box 12233, MD EC-21
Research Triangle Park, NC  27709
Telephone:  (919) 541-4980
FAX:  (919) 541-4937
Email:  collman@niehs.nih.gov

Direct inquiries regarding grants management matters to:

Joanne Wojcik
Procurement and Grants Office
Centers for Disease Control and Prevention
2920 Brandywine Road, MS-E13
Atlanta, GA  30341-4146
Telephone:  (770) 488-2717
FAX:  (770) 488-2777
Email:  jcw6@cdc.gov

William Wells
Grants Administration Branch
National Cancer Institute
6120 Executive Boulevard, Room 243
Bethesda, MD  20892-7150
Telephone:  (301) 496-7800, ext. 250
FAX:  (301) 496-8601
Email:  wellsw@gab.nci.nih.gov

William Darby
Division of Extramural Affairs
National Heart, Lung, and Blood Institute
6701 Rockledge Drive, Suite 7128
Bethesda, MD  20892-7128
Telephone:  (301) 435-0144
FAX:  (301) 480-3310
Email:  william_darby@nih.gov

Crystal Ferguson
Grants and Contracts Management Office
National Institute on Aging
7201 Wisconsin Avenue, Suite 2N212, MSC 9205
Bethesda, MD  20892-9205
Telephone:  (301) 496-1472
FAX:  (301) 402-3672
Email:  FergusoC@exmur.nia.nih.gov

Ed Ellis
Grants Management Officer
National Institute on Alcohol Abuse and Alcoholism
6000 Executive Boulevard MSC 7003
Bethesda, Maryland  20892-7003
Telephone:  301-443-4706
FAX:  301-443-3891
Internet address: eellis@willco.niaaa.nih.gov

Pamela Fleming
Division of Extramural Activities
National Institute of Allergy and Infectious Diseases
6700-B Rockledge Drive, MSC 7614
Bethesda, MD  20892-7614
Bethesda, MD  20817 (for express/courier service)
Telephone: (301) 402-6580
FAX:  (301) 480-3780
Email:  pf49e@nih.gov

Sally A. Nichols
Grants Management Officer
National Institute of Arthritis and Musculoskeletal and Skin Diseases
6500 Center Drive, Room 5AS-49F
Bethesda, MD 20892-6500
Telephone:  (301) 594-3535
FAX:  (301) 480-5450
Email:  jp149d@nih.gov

Sharon Hunt
Grants Management Officer
National Institute on Deafness and Other Communication Disorders
6120 Executive Boulevard, Room 400-B, MSC 7180
Bethesda, MD  20892-7180
Telephone:  (301) 402-0909
Email:  sh79f@nih.gov

David Mineo
Division of Extramural Research and Training
National Institute of Environmental Health Sciences
P.O. Box 12233, MD EC-22
Research Triangle Park, NC  27709-2233
Telephone:  (919) 541-1373
FAX:  (919) 541-2860
Email:  mineo@niehs.nih.gov

AUTHORITY AND REGULATIONS

This program is described in the Catalog of Federal Domestic Assistance Nos.
93.262 NIOSH; 93.393 NCI; 93.837, 93.838, and 93.839 NHLBI; 93.866 NIA; 93.273
NIAAA; 93.855, 93.856 NIAID; 93.846 NIAMS; 93.173 NIDCD; and 93.113 and 93.115
NIEHS.  This program is authorized under the Public Health Service Act, as
amended, Section 301(a) [42 U.S.C. 241(a)], and the Occupational Safety and
Health Act of 1970, Section 20(a) [29 U.S.C. 669(a)].  The applicable program
regulation is 42 CFR Part 52.

The CDC and NIH strongly encourage all grant and contract recipients to
provide a smoke-free workplace and promote the non-use of all tobacco
products.  In addition, Public Law 103-227, the Pro-Children Act of 1994,
prohibits smoking in certain facilities (or in some cases, any portion of a
facility) in which regular or routine education, library, day care, health
care or early childhood development services are provided to children.  This
is consistent with the PHS mission to protect and advance the physical and
mental health of the American people.

Return to Volume Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.